About Fizimed
Fizimed is a company based in Strasbourg (France) founded in 2017 by Emeline Hahn, Julien Guay, Allan Mabilais, and Paul Grandemange.. Fizimed has raised $4.35 million across 1 funding round from investors including UNIQA Group, Bpifrance and UI Investissement. Fizimed operates in a competitive market with competitors including Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and Atlantic Therapeutics, among others.
- Headquarter Strasbourg, France
- Founders Emeline Hahn, Julien Guay, Allan Mabilais, Paul Grandemange
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Fizimed
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.35 M (USD)
in 1 rounds
-
Latest Funding Round
$4.35 M (USD), Series A
Mar 13, 2025
-
Investors
UNIQA Group
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Fizimed
Fizimed has successfully raised a total of $4.35M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.35 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $4.4M
-
First Round
First Round
(13 Mar 2025)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series A - Fizimed | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fizimed
Fizimed has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include UNIQA Group, Bpifrance and UI Investissement. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UI Investissement is engaged in private equity and investment services.
|
Founded Year | Domain | Location | |
|
Diversified insurance firm
|
Founded Year | Domain | Location | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fizimed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Fizimed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fizimed Comparisons
Competitors of Fizimed
Fizimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and Atlantic Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| domain | founded_year | HQ Location |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| domain | founded_year | HQ Location |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| domain | founded_year | HQ Location |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
|
| domain | founded_year | HQ Location |
Developer of active implantable devices for urological incontinence
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fizimed
Frequently Asked Questions about Fizimed
When was Fizimed founded?
Fizimed was founded in 2017 and raised its 1st funding round 8 years after it was founded.
Where is Fizimed located?
Fizimed is headquartered in Strasbourg, France. It is registered at Strasbourg, Grand Est, France.
Who is the current CEO of Fizimed?
Emeline Hahn is the current CEO of Fizimed. They have also founded this company.
Is Fizimed a funded company?
Fizimed is a funded company, having raised a total of $4.35M across 1 funding round to date. The company's 1st funding round was a Series A of $4.35M, raised on Mar 13, 2025.
What does Fizimed do?
Fizimed was founded in 2017 in Strasbourg, France, and operates in the medical device sector. The Emy device, a wireless probe linked to a mobile application, is produced for perineal rehabilitation. It supports home-based exercises that supplement practitioner-led sessions, with progress monitored remotely by healthcare providers. Operations focus on enabling independent patient training while integrating with professional care protocols.
Who are the top competitors of Fizimed?
Fizimed's top competitors include Axonics, NeuSpera Medical and Laborie Medical.
Who are Fizimed's investors?
Fizimed has 3 investors. Key investors include UNIQA Group, Bpifrance, and UI Investissement.